RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:How Barclays Capital values Small Cap Oncology namesYou'd be highly welcomed by the market makers. If past pattern holds, you will make money. FYI - it appears the "fast track" designation is handed out pretty often. You do have to apply, so THTX is pushing. I think there are further designations to come -- the best being Break Through Therapy. So I guess it highlights you are on the path with the FDA. Definitely makes the regulatory process easier as you can piece-meal file the parts of you applications as you finish it in the trials.
So good news, but like you say, uneducated algo traders just jumping in pre market. I do hope it corrects for all this dilution puke though . Let's hold that $3!!!!
Bucknelly21 wrote: I wonder how risky it would be to sell during pre market pump and buy back at open lol